Safety, quality & education

Statistically significant differences versus convincing evidence of real treatment effects: an analysis of the false positive risk for single-centre trials in anaesthesia

Br J AnaesthPublished Meta-research study

Authors' conclusion

Our findings suggest that a substantial proportion of single-centre trials in anaesthesia reporting statistically significant differences provide limited evidence of real treatment effects, or, alternatively, required an implausibly high prior belief in a real treatment effect.

Study context

Population
Single-centre RCTs in 10 anaesthesia journals over 6 yr with a statistically significant difference in a primary binary outcome
Comparison
False positive risk (FPR) calculated by the Gunel vs Kass Bayes factor methods
Outcome
False positive risk (FPR) for equal pretest probabilities of 0.5
Methodological detailssystematic review of single-centre randomised trials, Bayesian analysis, false positive risk
  • Systematic review of single-centre randomised trials
  • Bayesian analysis
  • False positive risk

Pooled result

As reported in the abstract

FPR, equal pretest probabilities of 0.5

Further pooled results

Median

OutcomeGunelKass
FPR in trials reporting P-values 0.01-0.05 (subgroup), equal pretest probabilities of 0.525% (IQR 16–30%)20% (IQR 16–25%)
FPR in trials reporting P-values 0.01-0.05 (subgroup), equal pretest probabilities of 0.5 — Trials reporting P-values 0.01-0.05 requiring a pretest probability >0.5 to achieve an FPR of 5%
More than 90%

Difference in FPR between the two methods

Median (IQR) difference in FPR calculated by the two methods
0% (0-2%)

Original publication

Statistically significant differences versus convincing evidence of real treatment effects: an analysis of the false positive risk for single-centre trials in anaesthesia. Br J Anaesth. Published 28 November 2023. doi:10.1016/j.bja.2023.10.036

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.